Will 2023 be the year that pharma M&A makes a comeback? By: MarketWatch January 12, 2023 at 13:29 PM EST A handful of acquisitions this week point to a more deal-friendly year for biopharma and biotech companies. Read More >> Related Stocks: Albireo Pharma, Inc. - Common Stock Amgen Amryt Pharma plc - American Depositary Shares Apellis Pharmaceuticals, Inc. - Common Stock AstraZeneca PLC - American Depositary Shares BioNTech SE - American Depositary Shares CinCor Pharma, Inc. - Common Stock Horizon Therapeutics Public Limited Company - Ordinary Shares Karuna Therapeutics, Inc. - Common Stock SPDR S&P Pharmaceuticals ETF SPDR Series Trust SPDR S&P Biotech ETF Xenon Pharmaceuticals Inc. - Common Shares
